Chris Shumway
CIK 1222119 · last filed 2023-06-09
Chris Shumway is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for FNCH, was dated Jun 9, 2023. Across all open-market trades the lifetime net is +$25.0M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
3
$25.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | 11,906,147 | $7.30 | $86.91M | $25.00M | 3 | 2023-06-09 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-09 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-25 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Mixed | +25,282,882 | $25.00M | EDGAR |